Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CollabRx Inc (NASDAQ:CLRX)

0.503
Delayed Data
As of Jul 31
 +0.003 / +0.60%
Today’s Change
0.46
Today|||52-Week Range
2.74
-20.16%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Production Equipment
MARKET CAP
$4.0M

Company Description

CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA.

Contact Information

CollabRx, Inc.
44 Montgomery Street
San Francisco California 94104-4811
P:(415) 248-5350
Investor Relations:

Employees

Shareholders

Individual stakeholders2.99%
Other institutional17.82%
Mutual fund holders0.39%

Top Executives

Thomas R. MikaChairman, President, CEO, CFO & Secretary
Clifford BaronChief Operating Officer
George LundbergChief Medical Officer & Editor-In-Chief
Smruti J. VidwansChief Scientist & Science Officer